Search - tctmd.com

Displaying 461 - 480 of 745

Sort: Relevancy | Date

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

August 26, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

News Daily News

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

August 15, 2017

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

Boston Scientific Scraps Biodegradable Scaffold Program

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

July 20, 2017

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

News Daily News

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

July 18, 2017

Cardiologists Issue Call to Action to Improve CVD Care for Women

News Daily News

Cardiologists Issue Call to Action to Improve CVD Care for Women

July 11, 2017

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

News Daily News

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

July 04, 2017

TCTMD’s Top 10 Most Popular Stories for June 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

July 03, 2017

Episode 22: The A-fib and ACS Overlap

Podcast TCTMD Talking Points

Episode 22: The A-fib and ACS Overlap

June 14, 2017

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

News Daily News

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

June 05, 2017

TCTMD’s Top 10 Most Popular Stories for May 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

June 01, 2017

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

May 31, 2017

News Industry News

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

May 26, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

News Conference News SCAI 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

May 15, 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

May 12, 2017

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

May 11, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.